How can you promote vaccine safety?

Nursing

Volumn 37, Issue 4, 2007, Pages 58-64

  Miller, Elaine R ^a   Iskander, John ^a   Pickering, Susanne ^a   Varricchio, Frederick ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CVF Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

DRUG CONTRAINDICATION; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; HEALTH CARE POLICY; HEALTH PROMOTION; HUMAN; INFORMATION SERVICE; INTERNET; NURSE ATTITUDE; NURSING; NURSING ASSESSMENT; ORGANIZATION AND MANAGEMENT; POSTMARKETING SURVEILLANCE; REVIEW; RISK FACTOR; SAFETY; UNITED STATES; VACCINATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; HEALTH POLICY; HEALTH PROMOTION; HUMANS; INFORMATION SERVICES; INTERNET; NURSE'S ROLE; NURSING ASSESSMENT; PRODUCT SURVEILLANCE, POSTMARKETING; RISK FACTORS; SAFETY MANAGEMENT; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VACCINATION; VACCINES;

EID: 34147158894     PISSN: 03604039     EISSN: 15388689     Source Type: Journal    
DOI: 10.1097/01.NURSE.0000266045.57534.1a     Document Type: Review

References (16)

1. CDC. Impact of vaccines universally recommended for children - United States, 1990-1998. Morbidity and Mortality Weekly Report. 48(12):243-248, April 2, 1999.
2. CDC. Summary of notifiable diseases - United States, 2004. Morbidity and Mortality Weekly Report. 53(53):1-79, June 16, 2006.
3. Kroger AT, et al. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Recommendations and Reports: Morbidity and Mortality Weekly Report. 55(RR-15):1-48, December 1, 2006.
4. National Childhood Vaccine Injury Act of 1986, at Section 2125 of the Public Health Service Act as codified at 42 U.S.C., Section 300aa.
5. Active immunization. In Pickering LK (ed), 2003 Report of the Committee on Infectious Diseases, 26th edition. Elk Grove Village, Ill., American Academy of Pediatrics, 2003.
6. Woo EJ, et al. Fatal syncope-related fall after immunization. Archives of Pediatrics & Adolescent Medicine. 159(11):1083, November 2005.
7. Bohlke K, et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics. 112(4):815-820, October 2003.
8. Chen RT, et al. The Vaccine Adverse Event Reporting System (VAERS). Vaccine. 12(6):542-550, May 1994.
9. Varricchio F, et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. The Pediatric Infectious Disease Journal. 23(4):287-294, April 2004.
10. Singleton JA, et al. An overview of the Vaccine Adverse Event Reporting System (VAERS) as a surveillance system. VAERS working group. Vaccine. 17(22):2908-2917, July 16, 1999.
11. Rosenthal S, Chen R. The reporting sensitivities of two passive surveillance systems for vaccine adverse events. American Journal of Public Health. 85(12):1706-1709, December 1995.
12. CDC. Measles - United States, 1992. Morbidity and Mortality Weekly Report. 42(19):378-381, May 21, 1993.
13. CDC. Measles - United States, 1989 and first 20 weeks 1990. Morbidity and Mortality Weekly Report. 39(21):353-355, 361-363, June 1, 1990.
14. CDC. Diphtheria epidemic - New independent states of the former Soviet Union, 1990-1994. Morbidity and Mortality Weekly Report. 44(10):177-181, March 17, 1995.
15. CDC. Update: Diphtheria epidemic - New independent states of the former Soviet Union, January 1995-March 1996. Morbidity and Mortality Weekly Report. 45(32):693-697, August 16, 1996.
16. Feikin DR, et al. Individual and community risks of measles and pertussis associated with personal exemptions to immunization. Journal of the American Medical Association. 284(24):3145-3150, December 27, 2000.